Nonlinear Dynamics and Waters Corporation announce co-development and co-marketing agreement, creating Life Science Research Partnership

(Newcastle, UK) Nonlinear Dynamics, a leading provider of bioinformatics solutions, and Waters Corporation (NYSE: WAT) announced today in advance of the 4th HUPO Annual World Congress a far-reaching co-development and co-marketing agreement. The agreement, described by the two companies as a Life Science Research Partnership, creates a formidable alliance within the proteomics market.

Initially the two companies are to work together to promote the synergies between Nonlinear's leading Progenesis 2D gel electrophoresis analysis solutions and Waters' ProteinLynx Global Server 2.2.5 (PLGS) protein mass-informatics system with its mass spectrometry systems for MALDI-MS/MS or ESI-MS/MS. The companies have also declared their intention to work together on diverse areas of further development, including multivariate approaches to discovery research and orthogonal label-free protein quantification strategies.

Mark McDowall, Strategic Development Manager at Waters MS Technologies Centre, said, "By bringing together these two leading bioinformatics platforms, our customers will benefit from an integrated proteomics work-flow strategy, innovative new discovery techniques and supplier confidence. We are looking forward very much to working further with Nonlinear, and foresee a number of exciting developments emerging over the coming months and years to facilitate integrated biology."

John Spreadbury, Group Sales and Marketing Director at Nonlinear Dynamics and CEO, Nonlinear USA Inc., added, "Waters has a fantastic reputation and pedigree in HPLC and mass spectrometry. This agreement adds significant weight to our existing partnerships in this area. We continue to strive to represent the de facto standard in 2D gel analysis systems, something we are well on the way to achieving. Agreements of this type enable an even wider user base to be free to make a qualitative software choice, and this can only be to Nonlinear's benefit."

About Waters Corporation

Waters Corporation [NYSE: WAT] holds worldwide leading positions in three complementary analytical technologies - high performance liquid chromatography (HPLC), mass spectrometry (MS) and thermal analysis (TA). These markets account for $4.4 billion of the overall $20 billion analytical instrumentation market. Waters is dedicated to leveraging life science research from biomarker discovery through advanced therapy development to the facilitation of novel molecular diagnostics.

Contact: Brian J. Murphy, Corporate Communications
Tel: +1 508-482-2614
Email: brian_j_Murphy@waters.com
Web: www.waters.com

About Nonlinear Dynamics Ltd

Nonlinear Dynamics develops proteomics analysis software that is different, ground-breaking and above all designed to help you generate reliable conclusions that are reproducible across labs. Our new way of thinking has been applied to LCMS, MALDI and 2D data analysis so you can make a real difference using a combination of the right techniques, your expertise and the Progenesis software. The TotalLab laboratory products for 1D gel analysis provide quick and simple quantitation through to in-depth lane relationship studies, as well as offering features for research that requires 21CFR part 11 compliance.

"Everything about Nonlinear Dynamics makes it a great company to work with..."
Merry L. Lindsey, Ph.D., Assistant Professor
University of Texas Health Science Center at San Antonio

Nonlinear sells and supports its products through its UK headquarters and its USA office, as well as a global network of partners and OEM resellers.

Contact: Beth Rossiter, Marketing Department
Email: beth.rossiter@nonlinear.com
Tel: +44 (0)191 230 2121

Released: 29 August 2005

Current press releases | Archive press releases